Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MVP regimen

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND & OBJECTIVE Non-small cell lung cancer (NSCLC) is hyposensitive to the normal first and second-line chemotherapy… Expand
Is this relevant?
2002
2002
To compare the effect,toxicity and quality of life(QOL)between Aidi-MVP regimen and MVP regimen alone in primary patients with… Expand
Is this relevant?
1996
1996
Combination chemotherapy with anti-proliferative agents is often used in patients with advanced non-small cell lung cancer (NSCLC… Expand
Is this relevant?
1995
1995
The MVP regimen has been the ECOG standard because of a slightly higher response rate, in spite of a significant toxicity… Expand
Is this relevant?